Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
167 SAR | +0.72% | +3.47% | -2.79% |
Mar. 20 | Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 14 | Dallah Healthcare Logs Higher FY23 Net Profit, Revenue | MT |
Business Summary
Sales per Business
SAR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Services
95.5
%
| 2,368 | 95.2 % | 2,809 | 95.5 % | +18.65% |
Medicine and Pharmaceutical Products
4.5
%
| 120 | 4.8 % | 133 | 4.5 % | +11.10% |
Sales per region
SAR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Saudi Arabia
100.0
%
| 2,488 | 100.0 % | 2,943 | 100.0 % | +18.28% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 67 | 08-03-28 | |
Salah Al-Faqih
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | - | |
Director/Board Member | 74 | 04-12-31 | |
Corporate Officer/Principal | - | - | |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Talal Al-Maiman
BRD | Director/Board Member | - | - |
Chairman | 67 | 93-12-31 | |
Mohialdeen Kamel
BRD | Director/Board Member | 43 | 16-10-20 |
Director/Board Member | - | 19-10-20 | |
Director/Board Member | 74 | 04-12-31 | |
Chief Executive Officer | 67 | 08-03-28 | |
Fahad Al-Kassim
BRD | Director/Board Member | 57 | 16-10-20 |
Amr Kamel
BRD | Director/Board Member | - | 19-10-20 |
Director/Board Member | - | - | |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 97,681,166 | 40,969,977 ( 41.94 %) | 0 | 41.94 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.79% | 4.32B | |
-18.90% | 16.51B | |
+4.50% | 12.53B | |
+4.81% | 11.74B | |
+2.43% | 10.06B | |
+29.69% | 8.71B | |
-4.75% | 7.57B | |
+19.68% | 7.22B | |
+5.46% | 6.68B | |
-5.47% | 4.17B |
- Stock Market
- Equities
- 4004 Stock
- Company Dallah Healthcare Company